Standard

Phospholipids to Total Lipids in Medium VLDL percentage

near APOB · rs934197

Where this position leads

Condition: Age-Related Macular Degeneration

rs934197 Condition: Age-Related Macular Degeneration Age-Related Macular Degeneration Condition rs934197 rs934197 near APOB

Strength of the evidence

3 / 4

Its strongest genetic-study result is p = 10−693, with 119 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 98,316 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.035 higher (95% confidence interval 0.03-0.04); p = 5 × 10−45.

How common The A allele had a frequency of about 34% in the people studied.

Where it sits Chromosome 2, band 2p24.1 — between genes, 0.5 kb from APOB.

What ClinVar records

Classification Benign for Familial hypercholesterolemia; criteria provided, single submitter (1 of 4 stars, 1 submitter), last evaluated 2022-06-23. ClinVar record 3250497 NM_000384.2(APOB):c.-644C>T

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-10-19 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AG
Korean KRGDB
A 11.6% · G 88.4%
Korean Korea4K
A 11.4% · G 88.6%
Korean Korea1K
A 11.3% · G 88.6%
Japanese ToMMo
A 8.1% · G 91.9%
World gnomAD
A 24.5% · G 75.5%
World 1000 Genomes
A 17.2% · G 82.8%
World TOPMed
A 24.4% · G 75.6%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

A/A Two copies of the version the research linked to Phospholipids to Total Lipids in Medium VLDL percentage. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Phospholipids to Total Lipids in Medium VLDL percentage. That is a smaller link than two copies.
G/G No copy of the version the research linked to Phospholipids to Total Lipids in Medium VLDL percentage. This is the starting point the study compared everyone against.
Source

Questions about rs934197

What is rs934197?

rs934197 is a single position in the genome, in or near the near APOB gene. Published research associates it with phospholipids to total lipids in medium vldl percentage. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs934197 linked to?

On MyGeneLog this position is linked to Age-Related Macular Degeneration. The research behind each link, and its sources, are set out on that condition page.

Does having rs934197 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs934197 come from?

GWAS Catalog, Ophthalmology science 2024, PMID:39091897. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Phospholipids to Total Lipids in Medium VLDL percentage (rs934197). MyGeneLog™. https://www.mygenelog.com/variants/rs934197

← See all variants